en-USen-GB
  • Tokyo 2-3 December 2019
    Tokyo 2-3 December 2019
  • Zurich 28-30 October 2019
    Zurich 28-30 October 2019
  • Peapack 14-16 October 2019
    Peapack 14-16 October 2019
  • Brussels 15-17 May 2019
    Brussels 15-17 May 2019
  • Danbury 8-10 April 2019
    Danbury 8-10 April 2019
  • Tokyo 5-6 November 2018
    Tokyo 5-6 November 2018
  • Paris, France 23-25 October 2018
    Paris, France 23-25 October 2018
  • Philadelphia, USA 2-4 October 2018
    Philadelphia, USA 2-4 October 2018
  • Princeton 1-3 May 2018
    Princeton 1-3 May 2018
  • Darmstadt, 15-17 May 2018
    Darmstadt, 15-17 May 2018

WHO WE ARE

The eClinical Forum is a global network of peers. It provides a non‐competitive environment for innovation, learning and collaboration in clinical research.


News from the eCF

Login to also view news for Members.

eClinical Forum 2020 Meetings Announced!
  • 857
  • Article rating: No rating

eClinical Forum 2020 Meetings Announced!

We are looking forward to seeing all of our members in 2020! A special thanks to all our hosting members.  Discussion topics will be announced closer to the event. We look forward to timely discussion with all of you! Please send in your topic suggestions to webmaster3@eclinicalforum.org

April 27-29 2020:  Helsinki Finland, hosted by Signant Health

May 11-13 2020:  New Jersey, USA hosted by Diligent Pharma

September 2020: Tokyo Japan, hosted by Bristol Myers Squibb - date to be announced

October 14-16 2020: Dublin, Ireland -- this is a global meeting aimed at getting our members from around the globe together, hosted by eClinical Forum

Birds-of-a-Feather Webinar & Discussion:  Investigator Oversight on eCOA data - what is a good evidence?
  • 556
  • Article rating: No rating

Birds-of-a-Feather Webinar & Discussion: Investigator Oversight on eCOA data - what is a good evidence?

January 29 2020; facilitated by Cinzia Piccini of Eli Lilly

As there are no regulatory detailed expectations on oversight by investigators on eCOA data, multiple approaches have been adopted across the industry (from log-in as evidence to notification/alerts or investigator signature on eCOA data). In general, as per other data sources, oversight for eCOA data should be continual and not once at the end of the study. In addition, oversight activities should be right-sized according to the criticality of the data and protocol requirements for compliance. Evidence of the oversight should be available during the conduct of the trial and enduring for the entire retention period.  The aim of this webinar is to allow participants to share different approaches and any knowledge of current expectations by regulatory inspectors.

 

2020 is our 20th Anniversary Year!
  • 648
  • Article rating: No rating

2020 is our 20th Anniversary Year!

A lot has happened in electronic support for clinical research in the last 20 years ... and eClinical Forum has been there discussing it all!  We are pleased to be celebrating our 20th anniversary year, stronger than ever with 45+ member companies (and growing), meetings on 3 continents, global webinars that have been attended by members in over 25 countries, very active project teams, meetings with regulators, and freely adding to the knowledge base of the industry. Any organization working in this space is welcome to join. Please see the membership tab on our website (www.eclinicalforum.org) or contact us for more information!  info@eclinicalforum.org

RSS

Theme picker

Not a member?
Visit the Membership page to learn 
How To Become a Member
(Join the eClinical Forum and learn how to leverage existing and emerging technologies for electronic clinical trials. Access an eClinical community, member-only knowledge, events and forums)

«December 2019»
MonTueWedThuFriSatSun
2526272829301
2
12/2/2019 - 12/3/2019 UTC
83

Asia Pacific Meeting in Tokyo to be hosted by Eli Lilly

The eClinical Forum offers a unique, non-commercial networking environment to learn, exchange information and ideas, collaborate on shared initiatives and to influence the future. The following areas will be discussed.

  • The evolving landscape of the Pharma/Clinical Research industry
  • Clinical Trial Operations
  • Regulatory / Compliance
  • Emerging Technologies/Processes
  • Trial of the Future
  • eCF Project Teams: Progressing shared initiatives
Read more
3
12/2/2019 - 12/3/2019 UTC
83

Asia Pacific Meeting in Tokyo to be hosted by Eli Lilly

The eClinical Forum offers a unique, non-commercial networking environment to learn, exchange information and ideas, collaborate on shared initiatives and to influence the future. The following areas will be discussed.

  • The evolving landscape of the Pharma/Clinical Research industry
  • Clinical Trial Operations
  • Regulatory / Compliance
  • Emerging Technologies/Processes
  • Trial of the Future
  • eCF Project Teams: Progressing shared initiatives
Read more
45678
9101112131415
16171819
92

Implementing eSRA: Sponsor Perspective

This document is written specifically for Sponsors to assist them in determining how to fit eCF's eSource-Readiness Assessment (eSRA) into their procedures for determining if data which originated on a  site's electronic health record system is suitable for use in their clinical trial. It shows the benefits of using a common assessment tool, provides suggestions for implementing eSRA, and shows a mapping of eSRA questions to regulatory authority statements/expectations.

Read more
202122
23242526272829
303112345

Upcoming events Events RSSiCalendar export